Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study

B. Tombal; M. Hussain; D. Penson; G. Attard; C. N. Sternberg; D. Phung; R. Morlock; K. Modelska; K. Ramaswamy; C. Ivanescu; F. Saad

doi:10.1093/annonc/mdy284.016

Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study

B. Tombal, M. Hussain, D. Penson, G. Attard, C. N. Sternberg, D. Phung, R. Morlock, K. Modelska, K. Ramaswamy, C. Ivanescu, F. Saad

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii278-viii279
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy284.016
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdy284.016

Cite this

Tombal, B., Hussain, M., Penson, D., Attard, G., Sternberg, C. N., Phung, D., Morlock, R., Modelska, K., Ramaswamy, K., Ivanescu, C., & Saad, F. (2018). Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii278-viii279. https://doi.org/10.1093/annonc/mdy284.016

@article{ec247de5ed674e79a8f97ec983a1a16f,

title = "Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study",

author = "B. Tombal and M. Hussain and D. Penson and G. Attard and Sternberg, {C. N.} and D. Phung and R. Morlock and K. Modelska and K. Ramaswamy and C. Ivanescu and F. Saad",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy284.016",

language = "English (US)",

volume = "29",

pages = "viii278--viii279",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Tombal, B, Hussain, M, Penson, D, Attard, G, Sternberg, CN, Phung, D, Morlock, R, Modelska, K, Ramaswamy, K, Ivanescu, C & Saad, F 2018, 'Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii278-viii279. https://doi.org/10.1093/annonc/mdy284.016

Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study. / Tombal, B.; Hussain, M.; Penson, D. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii278-viii279.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide

T2 - Results from the PROSPER study

AU - Tombal, B.

AU - Hussain, M.

AU - Penson, D.

AU - Attard, G.

AU - Sternberg, C. N.

AU - Phung, D.

AU - Morlock, R.

AU - Modelska, K.

AU - Ramaswamy, K.

AU - Ivanescu, C.

AU - Saad, F.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85061110425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061110425&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy284.016

DO - 10.1093/annonc/mdy284.016

M3 - Article

C2 - 32136637

SN - 0923-7534

VL - 29

SP - viii278-viii279

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Tombal B, Hussain M, Penson D, Attard G, Sternberg CN, Phung D et al. Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii278-viii279. doi: 10.1093/annonc/mdy284.016

Prolonged urinary and bowel symptom control in men with non-metastatic castration-resistant prostate cancer (nmCRPC) treated with enzalutamide: Results from the PROSPER study

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this